There has been $4.25B capital invested in Artificial Intelligence & Machine Learning in July of 2022. A 22.7% decrease from June 2022. Total of 346 deals (more data available)
GOAL: Our goal is to find people that like to share ideas via Zoom or fun events worldwide. You must be an accredited investor that is active in Charity and investing in change. If you like to laugh often even better!
Sorry it is the weekend and both cartoon are too funny! Data below cartoons!
DATA DUMP (more data in Mindshare groups)
ContentSquare (funded) The company received debt financing in the form of a loan from Kreos Capital on an undisclosed date. Previously, the company raised $600 million of Series F through a combination of debt and equity on July 20, 2022, putting the company’s pre-money valuation at $5 billion. The equity portion of Series F funding was led by Sixth Street Partners with participation from SoftBank Group, BlackRock Private Equity Partners, Eurazeo, Canaan Partners, Highland Europe, Bpifrance, KKR Financial, and LionTree. A debt portion of $200 million was provided by BNP Paribas, Crédit Agricole Corporate & Investment Bank, Goldman Sachs, JP Morgan, and Société Générale. The funds will be used to scale investments in innovation, both organically and through M&A, support long-term growth in key markets, expand to new territories and deliver greater impact in areas where it can really make a difference, including digital accessibility, privacy & sustainability.
Biofourmis (funded) The company raised $320 million of Series D venture funding in a deal led by General Atlantic, 5050 Capital on July 27, 2022, putting the company’s pre-money valuation at $1 billion. CVS Health and Intel Capital also participated in the round. The funds will be used to scale up its virtual care offerings. Delfi Diagnostics The company raised $225 million of Series B venture funding in a deal led by DFJ Growth on July 18, 2022, putting the company’s pre-money valuation at $400 million. Eli Lilly, OrbiMed, Foresite Capital Management, Northpond Ventures, Cowen Healthcare Investments, Windham Venture Partners, Menlo Ventures, Illumina Ventures, Samsara BioCapital, AV8 Ventures, Point72 Ventures, Osage University Partners, Initiate Ventures, Open Field Capital, PTX Capital, Brown Advisory, Point Field Partners, Rock Springs Capital, and other undisclosed investors also participated in the round. The funds will be used for the continued development and commercialization of high-quality and accessible blood tests for single cancer early detection, multi-cancer early detection, and treatment monitoring.
Cleerly (Funded) The company raised $192 million of Series C venture funding in a deal led by Fidelity Management & Research and T. Rowe Price on July 25, 2022, putting the company’s pre-money valuation at $408 million. Cigna Ventures, Novartis, Sands Capital, Heartland, LRVHealth, Vensana Capital, New Leaf Venture, digiTx, Presight Capital, Breyer Capital, Peter Thiel, Mirae Asset Capital and Piper Sandler also participated in the round. The funds will be used to expand the company’s team as well as extend its commercial reach to broaden patient and physician access to its comprehensive technology-enabled care pathway across the entire continuum of disease presentation-from and early diagnosis of heart disease to ensure that ongoing treatments are effective for those who have that elevated risk or symptoms and will invest in additional large-scale outcomes research to establish it as the standard of care supporting physicians through personalized evaluation and treatment of heart disease.
May Mobility (funded) The company raised $111 million of Series C venture funding from Tokio Marine HCC and State Farm Ventures on July 12, 2022. The funds will be used to triple the corporate headcount, particularly in engineering, and also to increase the number of vehicle deployments in the U.S. and Japan. Previously, the company raised an undisclosed amount of venture funding from Bridgestone Americas on March 21, 2022. The funds will be used for its shared mission of providing safe and sustainable mobility solutions on a global scale.
ContentSquare (funded) The company received debt financing in the form of a loan from Kreos Capital on an undisclosed date. Previously, the company raised $600 million of Series F through a combination of debt and equity on July 20, 2022, putting the company’s pre-money valuation at $5 billion. The equity portion of Series F funding was led by Sixth Street Partners with participation from SoftBank Group, BlackRock Private Equity Partners, Eurazeo, Canaan Partners, Highland Europe, Bpifrance, KKR Financial, and LionTree. A debt portion of $200 million was provided by BNP Paribas, Crédit Agricole Corporate & Investment Bank, Goldman Sachs, JP Morgan, and Société Générale. The funds will be used to scale investments in innovation, both organically and through M&A, support long-term growth in key markets, expand to new territories and deliver greater impact in areas where it can really make a difference, including digital accessibility, privacy & sustainability.
Biofourmis (funded) The company raised $320 million of Series D venture funding in a deal led by General Atlantic, 5050 Capital on July 27, 2022, putting the company’s pre-money valuation at $1 billion. CVS Health and Intel Capital also participated in the round. The funds will be used to scale up its virtual care offerings. Delfi Diagnostics The company raised $225 million of Series B venture funding in a deal led by DFJ Growth on July 18, 2022, putting the company’s pre-money valuation at $400 million. Eli Lilly, OrbiMed, Foresite Capital Management, Northpond Ventures, Cowen Healthcare Investments, Windham Venture Partners, Menlo Ventures, Illumina Ventures, Samsara BioCapital, AV8 Ventures, Point72 Ventures, Osage University Partners, Initiate Ventures, Open Field Capital, PTX Capital, Brown Advisory, Point Field Partners, Rock Springs Capital, and other undisclosed investors also participated in the round. The funds will be used for the continued development and commercialization of high-quality and accessible blood tests for single cancer early detection, multi-cancer early detection, and treatment monitoring.
Cleerly (funded) The company raised $192 million of Series C venture funding in a deal led by Fidelity Management & Research and T. Rowe Price on July 25, 2022, putting the company’s pre-money valuation at $408 million. Cigna Ventures, Novartis, Sands Capital, Heartland, LRVHealth, Vensana Capital, New Leaf Venture, digiTx, Presight Capital, Breyer Capital, Peter Thiel, Mirae Asset Capital and Piper Sandler also participated in the round. The funds will be used to expand the company’s team as well as extend its commercial reach to broaden patient and physician access to its comprehensive technology-enabled care pathway across the entire continuum of disease presentation-from and early diagnosis of heart disease to ensure that ongoing treatments are effective for those who have that elevated risk or symptoms and will invest in additional large-scale outcomes research to establish it as the standard of care supporting physicians through personalized evaluation and treatment of heart disease.
May Mobility (funded) The company raised $111 million of Series C venture funding from Tokio Marine HCC and State Farm Ventures on July 12, 2022. The funds will be used to triple the corporate headcount, particularly in engineering, and also to increase the number of vehicle deployments in the U.S. and Japan. Previously, the company raised an undisclosed amount of venture funding from Bridgestone Americas on March 21, 2022. The funds will be used for its shared mission of providing safe and sustainable mobility solutions on a global scale.
Merlin Labs (funded) The company raised $105 million of Series B venture funding in a deal led by Snowpoint Ventures and Baillie Gifford on July 13, 2022. GV, Business Creation Capital and First Round Capital also participated in the round. The funds will be used to continue to achieve certification milestones and to build on that record of trust and safety. Previously, the company raised $120 million of Series B venture funding from GV, Quiet Capital and Snowpoint Ventures on May 27, 2021. First Round Capital and Baillie Gifford also participated in the round.
Immutics (funded) The company raised $100 million of venture funding from undisclosed investors on July 6, 2022. Previously, the company raised $49.75 million of funding from undisclosed investors on July 13, 2020. PengXing Intelligence The company raised over $100 million of Series A venture funding in a deal led by IDG Capital on July 12, 2022. Guangzhou Xiaopeng Motors Technology also participated in the round. This funding will be used to further strengthen the company’s full-stack R&D investment in robot hardware ontology and machine intelligence. Previously, the company raised an undisclosed amount of venture funding in October, 2020.
Tecton (funded) The company raised $100 million of Series C venture funding in a deal led by Kleiner Perkins on July 12, 2022. Databricks, Snowflake Ventures, Tiger Global Management, Bain Capital Ventures, Andreessen Horowitz and Sequoia Capital also participated in the round. The funds will be used to scale Tecton’s engineering and go-to-market teams and will help further build and strengthen both Tecton’s feature platform for ML and the Feast open source feature store, enabling organizations of all sizes to build and deploy automated ML into live, customer-facing applications and business processes, quickly and at scale. The company raised $105 million of Series B venture funding in a deal led by Snowpoint Ventures and Baillie Gifford on July 13, 2022. GV, Business Creation Capital and First Round Capital also participated in the round. The funds will be used to continue to achieve certification milestones and to build on that record of trust and safety. Previously, the company raised $120 million of Series B venture funding from GV, Quiet Capital and Snowpoint Ventures on May 27, 2021. First Round Capital and Baillie Gifford also participated in the round.
Immutics (funded) The company raised $100 million of venture funding from undisclosed investors on July 6, 2022. Previously, the company raised $49.75 million of funding from undisclosed investors on July 13, 2020. PengXing Intelligence The company raised over $100 million of Series A venture funding in a deal led by IDG Capital on July 12, 2022. Guangzhou Xiaopeng Motors Technology also participated in the round. This funding will be used to further strengthen the company’s full-stack R&D investment in robot hardware ontology and machine intelligence. Previously, the company raised an undisclosed amount of venture funding in October, 2020.
Tecton (funded) The company raised $100 million of Series C venture funding in a deal led by Kleiner Perkins on July 12, 2022. Databricks, Snowflake Ventures, Tiger Global Management, Bain Capital Ventures, Andreessen Horowitz and Sequoia Capital also participated in the round. The funds will be used to scale Tecton’s engineering and go-to-market teams and will help further build and strengthen both Tecton’s feature platform for ML and the Feast open source feature store, enabling organizations of all sizes to build and deploy automated ML into live, customer-facing applications and business processes, quickly and at scale.
More data available for members of group.
You must log in to post a comment.